Treatment of iron deficiency anemia associated with gastrointestinal tract diseases

World Journal of Gastroenterology

Volumn 16, Issue 22, 2010, Pages 2720-2725

  Bayraktar, Ulas D ^a   Bayraktar, Soley ^a  

^a UNIVERSITY OF MIAMI   (United States)

Author keywords

Anemia; Inflammatory bowel disease; Intravenousiron; Iron deficiency; Oral iron

Indexed keywords

ANTIANEMIC AGENT; AZATHIOPRINE; FERRIC CARBOXYMALTOSE; FERRIC HYDROXIDE SUCROSE; FERRITIN; FERROUS FUMARATE; FERROUS GLUCONATE; FERROUS SULFATE; IRON; IRON DEXTRAN; MERCAPTOPURINE; MESALAZINE; SULFALAZINE; TRANSFERRIN RECEPTOR; UNCLASSIFIED DRUG;

ANAPHYLAXIS; ANEMIA; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; COLONOSCOPY; CONTROLLED DRUG RELEASE; DIARRHEA; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG ABSORPTION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ENTERITIS; EPIGASTRIC PAIN; ERYTHROCYTE COUNT; ERYTHROCYTE TRANSFUSION; FERRITIN BLOOD LEVEL; GASTROINTESTINAL DISEASE; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL SYMPTOM; HUMAN; INJECTION PAIN; INJECTION SITE PAIN; IRON BLOOD LEVEL; IRON DEFICIENCY ANEMIA; IRON THERAPY; LOW DRUG DOSE; NONHUMAN; RETICULOCYTE HEMOGLOBIN CONTENT; SINGLE DRUG DOSE;

EID: 77954253358     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v16.i22.2720     Document Type: Article

References (47)

1. Novacek G. Plummer-Vinson syndrome. Orphanet J Rare Dis 2006; 1: 36
2. Earley CJ. Clinical practice. Restless legs syndrome. N Engl J Med 2003; 348: 2103-2109
3. Baccini F, Spiriti MA, Vannella L, Monarca B, Delle Fave G, Annibale B. Unawareness of gastrointestinal symptomatology in adult coeliac patients with unexplained iron-deficiency anaemia presentation. Aliment Pharmacol Ther 2006; 23: 915-921
4. Hershko C, Ianculovich M, Souroujon M. A hematologist's view of unexplained iron deficiency anemia in males: impact of Helicobacter pylori eradication. Blood Cells Mol Dis 2007; 38: 45-53
5. Favier A, Ruffieux D. Physiological variations of serum levels of copper, zinc, iron and manganese. Biomed Pharmacother 1983; 37: 462-466
6. Guyatt GH, Oxman AD, Ali M, Willan A, McIlroy W, Patterson C. Laboratory diagnosis of iron-deficiency anemia: an overview. J Gen Intern Med 1992; 7: 145-153
7. Mast AE, Blinder MA, Gronowski AM, Chumley C, Scott MG. Clinical utility of the soluble transferrin receptor and comparison with serum ferritin in several populations. Clin Chem 1998; 44: 45-51
8. Brugnara C, Schiller B, Moran J. Reticulocyte hemoglobin equivalent (Ret He) and assessment of iron-deficient states. Clin Lab Haematol 2006; 28: 303-308
9. Ganti AK, Moazzam N, Laroia S, Tendulkar K, Potti A, Mehdi SA. Predictive value of absent bone marrow iron stores in the clinical diagnosis of iron deficiency anemia. In Vivo 2003; 17: 389-392
10. Stephens MR, Hopper AN, White SR, Jugool S, Stratford R, Lewis WG, Allison MC. Colonoscopy first for iron-deficiency anaemia: a Numbers Needed to Investigate approach. QJM 2006; 99: 389-395
11. Rockey DC, Cello JP. Evaluation of the gastrointestinal tract in patients with iron-deficiency anemia. N Engl J Med 1993; 329: 1691-1695
12. Kepczyk T, Kadakia SC. Prospective evaluation of gastrointestinal tract in patients with iron-deficiency anemia. Dig Dis Sci 1995; 40: 1283-1289
13. Hébert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, Tweeddale M, Schweitzer I, Yetisir E. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 1999; 340: 409-417
14. Verdon F, Burnand B, Stubi CL, Bonard C, Graff M, Michaud A, Bischoff T, de Vevey M, Studer JP, Herzig L, Chapuis C, Tissot J, Pécoud A, Favrat B. Iron supplementation for unexplained fatigue in non-anaemic women: double blind randomised placebo controlled trial. BMJ 2003; 326: 1124
15. Bruner AB, Joffe A, Duggan AK, Casella JF, Brandt J. Randomised study of cognitive effects of iron supplementation in non-anaemic iron-deficient adolescent girls. Lancet 1996; 348: 992-996
16. Hallberg L, Ryttinger L, Sölvell L. Side-effects of oral iron therapy. A double-blind study of different iron compounds in tablet form. Acta Med Scand Suppl 1966; 459: 3-10
17. Brick C, Curry H, Hanna C, Knipfer M, Taylor L. Adverse effects of iron supplementation a comparative trial of a waxmatrix iron preparation and conventional ferrous sulfate tablets. Clin Ther 1985; 7: 568-573
18. Jacobs P, Fransman D, Coghlan P. Comparative bioavailability of ferric polymaltose and ferrous sulphate in irondeficient blood donors. J Clin Apher 1993; 8: 89-95
19. Rockey DC. Treatment of iron deficiency. Gastroenterology 2006; 130: 1367-1368
20. Rimon E, Kagansky N, Kagansky M, Mechnick L, Mashiah T, Namir M, Levy S. Are we giving too much iron? Low-dose iron therapy is effective in octogenarians. Am J Med 2005; 118: 1142-1147
21. Chertow GM, Mason PD, Vaage-Nilsen O, Ahlmén J. Update on adverse drug events associated with parenteral iron. Nephrol Dial Transplant 2006; 21: 378-382
22. Silverstein SB, Rodgers GM. Parenteral iron therapy options. Am J Hematol 2004; 76: 74-78
23. Muñoz M, Gómez-Ramírez S, García-Erce JA. Intravenous iron in inflammatory bowel disease. World J Gastroenterol 2009; 15: 4666-4674
24. Ganzoni AM. [Intravenous iron-dextran: therapeutic and experimental possibilities] Schweiz Med Wochenschr 1970; 100: 301-303
25. Walters GO, Miller FM, Worwood M. Serum ferritin concentration and iron stores in normal subjects. J Clin Pathol 1973; 26: 770-772
26. Yee J, Besarab A. Iron sucrose: the oldest iron therapy becomes new. Am J Kidney Dis 2002; 40: 1111-1121
27. Van Wyck DB. Labile iron: manifestations and clinical implications. J Am Soc Nephrol 2004; 15 Suppl 2: S107-S111
28. Kulnigg S, Stoinov S, Simanenkov V, Dudar LV, Karnafel W, Garcia LC, Sambuelli AM, D'Haens G, Gasche C. A novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: the ferric carboxymaltose (FERINJECT) randomized controlled trial. Am J Gastroenterol 2008; 103: 1182-1192
29. Kulnigg S, Gasche C. Systematic review: managing anaemia in Crohn's disease. Aliment Pharmacol Ther 2006; 24: 1507-1523
30. Gasché C, Reinisch W, Lochs H, Parsaei B, Bakos S, Wyatt J, Fueger GF, Gangl A. Anemia in Crohn's disease. Importance of inadequate erythropoietin production and iron deficiency. Dig Dis Sci 1994; 39: 1930-1934
31. Ormerod TP. Anaemia in ulcerative colitis. Proc R Soc Med 1968; 61: 931
32. Gomollón F, Gisbert JP. Anemia and inflammatory bowel diseases. World J Gastroenterol 2009; 15: 4659-4665
33. Schröder O, Mickisch O, Seidler U, de Weerth A, Dignass AU, Herfarth H, Reinshagen M, Schreiber S, Junge U, Schrott M, Stein J. Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease--a randomized, controlled, open-label, multicenter study. Am J Gastroenterol 2005; 100: 2503-2509
34. Erichsen K, Ulvik RJ, Nysaeter G, Johansen J, Ostborg J, Berstad A, Berge RK, Hausken T. Oral ferrous fumarate or intravenous iron sucrose for patients with inflammatory bowel disease. Scand J Gastroenterol 2005; 40: 1058-1065
35. Gisbert JP, Bermejo F, Pajares R, Pérez-Calle JL, Rodríguez M, Algaba A, Mancenido N, de la Morena F, Carneros JA, McNicholl AG, González-Lama Y, Maté J. Oral and intravenous iron treatment in inflammatory bowel disease: hematological response and quality of life improvement. Inflamm Bowel Dis 2009; 15: 1485-1491
36. Lindgren S, Wikman O, Befrits R, Blom H, Eriksson A, Grännö C, Ung KA, Hjortswang H, Lindgren A, Unge P. Intravenous iron sucrose is superior to oral iron sulphate for correcting anaemia and restoring iron stores in IBD patients: A randomized, controlled, evaluator-blind, multicentre study. Scand J Gastroenterol 2009; 44: 838-845
37. Allen LH. Iron supplements: scientific issues concerning efficacy and implications for research and programs. J Nutr 2002; 132: 813S-819S
38. Smith MD, Pannacciulli IM. Absorption of inorganic iron from graded doses: its significance in relation to iron absorption tests and mucosal block theory. Br J Haematol 1958; 4: 428-434
39. Werner E, Kaltwasser JP, Ihm P. [Oral iron treatment: intestinal absorption and the influence of a meal (author's transl)] Dtsch Med Wochenschr 1977; 102: 1061-1064
40. Helmer OM, Emerson CP. The iron content of the whole blood of normal individuals. J Biol Chem 1934; 104: 157-161
41. Carrier J, Aghdassi E, Platt I, Cullen J, Allard JP. Effect of oral iron supplementation on oxidative stress and colonic inflammation in rats with induced colitis. Aliment Pharmacol Ther 2001; 15: 1989-1999
42. Carrier J, Aghdassi E, Cullen J, Allard JP. Iron supplementation increases disease activity and vitamin E ameliorates the effect in rats with dextran sulfate sodium-induced colitis. J Nutr 2002; 132: 3146-3150
43. Seril DN, Liao J, Ho KL, Warsi A, Yang CS, Yang GY. Dietary iron supplementation enhances DSS-induced colitis and associated colorectal carcinoma development in mice. Dig Dis Sci 2002; 47: 1266-1278
44. Reifen R, Matas Z, Zeidel L, Berkovitch Z, Bujanover Y. Iron supplementation may aggravate inflammatory status of colitis in a rat model. Dig Dis Sci 2000; 45: 394-397
45. Erichsen K, Milde AM, Arslan G, Helgeland L, Gudbrandsen OA, Ulvik RJ, Berge RK, Hausken T, Berstad A. Low-dose oral ferrous fumarate aggravated intestinal inflammation in rats with DSS-induced colitis. Inflamm Bowel Dis 2005; 11: 744-748
46. de Silva AD, Tsironi E, Feakins RM, Rampton DS. Efficacy and tolerability of oral iron therapy in inflammatory bowel disease: a prospective, comparative trial. Aliment Pharmacol Ther 2005; 22: 1097-1105
47. Kulnigg S, Teischinger L, Dejaco C, Waldhör T, Gasche C. Rapid recurrence of IBD-associated anemia and iron deficiency after intravenous iron sucrose and erythropoietin treatment. Am J Gastroenterol 2009; 104: 1460-1467